Vascular endothelial growth factor isoforms display distinct activities in promoting tumor angiogenesis at different anatomic sites

P. Guo, L. Xu, S. Pan, R. A. Brekken, S. T. Yang, G. B. Whitaker, M. Nagane, P. E. Thorpe, J. S. Rosenbaum, H. J S Huang, W. K. Cavenee, S. Y. Cheng

Research output: Contribution to journalArticle

71 Citations (Scopus)

Abstract

The gene for the major angiogenic factor, vascular endothelial growth factor (VEGF), encodes several spliced isoforms. We reported previously that overexpression of two VEGF isoforms, VEGF121 and VEGF165, by human glioma U87 MG cells induced tumor-associated intracerebral hemorrhage, whereas expression of a third form, VEGF189, did not cause vessel rupture. Here, we test whether these VEGF isoforms have distinct activities for enhancing vascularization and growth of gliomas in mice. U87 MG cells that overexpressed VEGF165 or VEGF189 grew more rapidly than the parental cells in both s.c. and intracranial (i.c.) locations. However, cells that overexpressed VEGF121 only showed enhancement of i.c. tumor growth but had a minimal effect on s.c. glioma progression. At both anatomical sties, VEGF165 and VEGF189 strongly augmented neovascularization, whereas VEGF121 only increased vessel density in brain tumors. In each type of glioma, expression of VEGF receptors -1 and -2 largely phenocopied the tumor vasculature, because increased VEGF/VEGF receptor-activated microvessel densities were strongly correlated with the angiogenicity and tumorigenicity elicited by the VEGF isoforms at both anatomical sites. One notable difference between the sites was the expression of vitronectin, a prototypic ligand of αvβ3 and αvβ5integrins, detected in i.c. but not in s.c., gliomas. Endothelial cell migration stimulated by VEGF121 was potentiated by vitronectin to a greater extent than that stimulated by VEGF165. This data demonstrates that VEGF isoforms have distinct activities at different anatomical sites and suggest that the microenvironment of different tissues affects the function of VEGF isoforms.

Original languageEnglish (US)
Pages (from-to)8569-8577
Number of pages9
JournalCancer Research
Volume61
Issue number23
StatePublished - Dec 1 2001

Fingerprint

Vascular Endothelial Growth Factor A
Protein Isoforms
Glioma
Neoplasms
Vitronectin
Hordeolum
Vascular Endothelial Growth Factor Receptor-1
Vascular Endothelial Growth Factor Receptor-2
Vascular Endothelial Growth Factor Receptor
Angiogenesis Inducing Agents
Cerebral Hemorrhage
Growth
Microvessels
Brain Neoplasms
Cell Movement
Rupture
Endothelial Cells
Ligands
Genes

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Vascular endothelial growth factor isoforms display distinct activities in promoting tumor angiogenesis at different anatomic sites. / Guo, P.; Xu, L.; Pan, S.; Brekken, R. A.; Yang, S. T.; Whitaker, G. B.; Nagane, M.; Thorpe, P. E.; Rosenbaum, J. S.; Huang, H. J S; Cavenee, W. K.; Cheng, S. Y.

In: Cancer Research, Vol. 61, No. 23, 01.12.2001, p. 8569-8577.

Research output: Contribution to journalArticle

Guo, P, Xu, L, Pan, S, Brekken, RA, Yang, ST, Whitaker, GB, Nagane, M, Thorpe, PE, Rosenbaum, JS, Huang, HJS, Cavenee, WK & Cheng, SY 2001, 'Vascular endothelial growth factor isoforms display distinct activities in promoting tumor angiogenesis at different anatomic sites', Cancer Research, vol. 61, no. 23, pp. 8569-8577.
Guo, P. ; Xu, L. ; Pan, S. ; Brekken, R. A. ; Yang, S. T. ; Whitaker, G. B. ; Nagane, M. ; Thorpe, P. E. ; Rosenbaum, J. S. ; Huang, H. J S ; Cavenee, W. K. ; Cheng, S. Y. / Vascular endothelial growth factor isoforms display distinct activities in promoting tumor angiogenesis at different anatomic sites. In: Cancer Research. 2001 ; Vol. 61, No. 23. pp. 8569-8577.
@article{4a7b427326774075b19896c6ad8d9027,
title = "Vascular endothelial growth factor isoforms display distinct activities in promoting tumor angiogenesis at different anatomic sites",
abstract = "The gene for the major angiogenic factor, vascular endothelial growth factor (VEGF), encodes several spliced isoforms. We reported previously that overexpression of two VEGF isoforms, VEGF121 and VEGF165, by human glioma U87 MG cells induced tumor-associated intracerebral hemorrhage, whereas expression of a third form, VEGF189, did not cause vessel rupture. Here, we test whether these VEGF isoforms have distinct activities for enhancing vascularization and growth of gliomas in mice. U87 MG cells that overexpressed VEGF165 or VEGF189 grew more rapidly than the parental cells in both s.c. and intracranial (i.c.) locations. However, cells that overexpressed VEGF121 only showed enhancement of i.c. tumor growth but had a minimal effect on s.c. glioma progression. At both anatomical sties, VEGF165 and VEGF189 strongly augmented neovascularization, whereas VEGF121 only increased vessel density in brain tumors. In each type of glioma, expression of VEGF receptors -1 and -2 largely phenocopied the tumor vasculature, because increased VEGF/VEGF receptor-activated microvessel densities were strongly correlated with the angiogenicity and tumorigenicity elicited by the VEGF isoforms at both anatomical sites. One notable difference between the sites was the expression of vitronectin, a prototypic ligand of αvβ3 and αvβ5integrins, detected in i.c. but not in s.c., gliomas. Endothelial cell migration stimulated by VEGF121 was potentiated by vitronectin to a greater extent than that stimulated by VEGF165. This data demonstrates that VEGF isoforms have distinct activities at different anatomical sites and suggest that the microenvironment of different tissues affects the function of VEGF isoforms.",
author = "P. Guo and L. Xu and S. Pan and Brekken, {R. A.} and Yang, {S. T.} and Whitaker, {G. B.} and M. Nagane and Thorpe, {P. E.} and Rosenbaum, {J. S.} and Huang, {H. J S} and Cavenee, {W. K.} and Cheng, {S. Y.}",
year = "2001",
month = "12",
day = "1",
language = "English (US)",
volume = "61",
pages = "8569--8577",
journal = "Journal of Cancer Research",
issn = "0099-7013",
publisher = "American Association for Cancer Research Inc.",
number = "23",

}

TY - JOUR

T1 - Vascular endothelial growth factor isoforms display distinct activities in promoting tumor angiogenesis at different anatomic sites

AU - Guo, P.

AU - Xu, L.

AU - Pan, S.

AU - Brekken, R. A.

AU - Yang, S. T.

AU - Whitaker, G. B.

AU - Nagane, M.

AU - Thorpe, P. E.

AU - Rosenbaum, J. S.

AU - Huang, H. J S

AU - Cavenee, W. K.

AU - Cheng, S. Y.

PY - 2001/12/1

Y1 - 2001/12/1

N2 - The gene for the major angiogenic factor, vascular endothelial growth factor (VEGF), encodes several spliced isoforms. We reported previously that overexpression of two VEGF isoforms, VEGF121 and VEGF165, by human glioma U87 MG cells induced tumor-associated intracerebral hemorrhage, whereas expression of a third form, VEGF189, did not cause vessel rupture. Here, we test whether these VEGF isoforms have distinct activities for enhancing vascularization and growth of gliomas in mice. U87 MG cells that overexpressed VEGF165 or VEGF189 grew more rapidly than the parental cells in both s.c. and intracranial (i.c.) locations. However, cells that overexpressed VEGF121 only showed enhancement of i.c. tumor growth but had a minimal effect on s.c. glioma progression. At both anatomical sties, VEGF165 and VEGF189 strongly augmented neovascularization, whereas VEGF121 only increased vessel density in brain tumors. In each type of glioma, expression of VEGF receptors -1 and -2 largely phenocopied the tumor vasculature, because increased VEGF/VEGF receptor-activated microvessel densities were strongly correlated with the angiogenicity and tumorigenicity elicited by the VEGF isoforms at both anatomical sites. One notable difference between the sites was the expression of vitronectin, a prototypic ligand of αvβ3 and αvβ5integrins, detected in i.c. but not in s.c., gliomas. Endothelial cell migration stimulated by VEGF121 was potentiated by vitronectin to a greater extent than that stimulated by VEGF165. This data demonstrates that VEGF isoforms have distinct activities at different anatomical sites and suggest that the microenvironment of different tissues affects the function of VEGF isoforms.

AB - The gene for the major angiogenic factor, vascular endothelial growth factor (VEGF), encodes several spliced isoforms. We reported previously that overexpression of two VEGF isoforms, VEGF121 and VEGF165, by human glioma U87 MG cells induced tumor-associated intracerebral hemorrhage, whereas expression of a third form, VEGF189, did not cause vessel rupture. Here, we test whether these VEGF isoforms have distinct activities for enhancing vascularization and growth of gliomas in mice. U87 MG cells that overexpressed VEGF165 or VEGF189 grew more rapidly than the parental cells in both s.c. and intracranial (i.c.) locations. However, cells that overexpressed VEGF121 only showed enhancement of i.c. tumor growth but had a minimal effect on s.c. glioma progression. At both anatomical sties, VEGF165 and VEGF189 strongly augmented neovascularization, whereas VEGF121 only increased vessel density in brain tumors. In each type of glioma, expression of VEGF receptors -1 and -2 largely phenocopied the tumor vasculature, because increased VEGF/VEGF receptor-activated microvessel densities were strongly correlated with the angiogenicity and tumorigenicity elicited by the VEGF isoforms at both anatomical sites. One notable difference between the sites was the expression of vitronectin, a prototypic ligand of αvβ3 and αvβ5integrins, detected in i.c. but not in s.c., gliomas. Endothelial cell migration stimulated by VEGF121 was potentiated by vitronectin to a greater extent than that stimulated by VEGF165. This data demonstrates that VEGF isoforms have distinct activities at different anatomical sites and suggest that the microenvironment of different tissues affects the function of VEGF isoforms.

UR - http://www.scopus.com/inward/record.url?scp=0035577770&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035577770&partnerID=8YFLogxK

M3 - Article

VL - 61

SP - 8569

EP - 8577

JO - Journal of Cancer Research

JF - Journal of Cancer Research

SN - 0099-7013

IS - 23

ER -